PayPay Securities’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $681 | Sell |
14
-3
| -18% | -$146 | 0.03% | 231 |
|
|
2025
Q1 | $605 | Sell |
17
-8
| -32% | -$285 | 0.03% | 244 |
|
|
2024
Q4 | $984 | Buy |
25
+19
| +317% | +$748 | 0.04% | 216 |
|
|
2024
Q3 | $282 | Sell |
6
-5
| -45% | -$235 | 0.03% | 178 |
|
|
2024
Q2 | $594 | Sell |
11
-7
| -39% | -$378 | 0.05% | 174 |
|
|
2024
Q1 | $1.23K | Sell |
18
-3
| -14% | -$205 | 0.06% | 177 |
|
|
2023
Q4 | $1.32K | Buy |
21
+5
| +31% | +$315 | 0.06% | 178 |
|
|
2023
Q3 | $6.04K | Buy |
16
+1
| +7% | +$377 | 0.28% | 87 |
|
|
2023
Q2 | $842 | Sell |
15
-3
| -17% | -$168 | 0.05% | 157 |
|
|
2023
Q1 | $814 | Sell |
18
-27
| -60% | -$1.22K | 0.05% | 166 |
|
|
2022
Q4 | $1.83K | Buy |
+45
| New | +$1.83K | 0.12% | 140 |
|